System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection — Guardant Health, Inc. (PMA P230009)
System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection — Guardant Health, Inc. (PMA P230009) is one of 9,000 device clearances in the DeviceClear dataset. Key details — Device name: System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection; Applicant: Guardant Health, Inc.; Clearance track:
| Device name | System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection |
|---|---|
| Applicant | Guardant Health, Inc. |
| Clearance track | PMA |
| Submission number | P230009 |
| Decision | OK30 |
| Decision date | 2025-09-23 |
| Date received | 2025-08-25 |
| Product code | PHP |
| Device class | 3 |
| Medical specialty | Unknown |
| Applicant location | CA |
| Source | openFDA device |
🔍 Search all device clearances →
$1999/mo
Try DeviceClear →